These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22615508)

  • 1. Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis.
    Maleki M; Karimi G; Tafaghodi M; Raftari S; Nahidi Y
    Indian J Dermatol; 2012 Mar; 57(2):118-22. PubMed ID: 22615508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy of intralesional Glucantime plus niosomal zinc sulphate in comparison with intralesional Glucantime plus cryotherapy in the treatment of acute cutaneous leishmaniasis, a randomized clinical trial.
    Farajzadeh S; Ahmadi R; Mohammadi S; Pardakhty A; Khalili M; Aflatoonian M
    J Parasit Dis; 2018 Dec; 42(4):616-620. PubMed ID: 30538362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Moradi S; Derakhshan R; Haftbaradaran E
    BMC Complement Altern Med; 2007 Apr; 7():13. PubMed ID: 17466071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between intralesional injection of zinc sulfate 2 % solution and intralesional meglumine antimoniate in the treatment of acute old world dry type cutaneous leishmaniasis: a randomized double-blind clinical trial.
    Farajzadeh S; Hakimi Parizi M; Haghdoost AA; Mohebbi A; Mohammadi S; Pardakhty A; Eybpoosh S; Heshmatkhah A; Vares B; Saryazdi S; Fekri AR; Mohebbi E
    J Parasit Dis; 2016 Sep; 40(3):935-9. PubMed ID: 27605813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, double-blind, controlled clinical trial.
    Firooz A; Khatami A; Khamesipour A; Nassiri-Kashani M; Behnia F; Nilforoushzadeh M; Pazoki-Toroudi H; Dowlati Y
    J Drugs Dermatol; 2005; 4(1):73-9. PubMed ID: 15696988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions.
    Jaffary F; Nilforoushzadeh MA; Siadat A; Haftbaradaran E; Ansari N; Ahmadi E
    Dermatol Res Pract; 2016; 2016():6462804. PubMed ID: 27148363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major.
    Jaffary F; Nilforoushzadeh MA; Tavakoli N; Zolfaghari B; Shahbazi F
    Adv Biomed Res; 2014; 3():111. PubMed ID: 24804185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis.
    Layegh P; Rajabi O; Jafari MR; Emamgholi Tabar Malekshah P; Moghiman T; Ashraf H; Salari R
    J Parasitol Res; 2011; 2011():656523. PubMed ID: 22174993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis.
    Iraji F; Vali A; Asilian A; Shahtalebi MA; Momeni AZ
    Dermatology; 2004; 209(1):46-9. PubMed ID: 15237267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran.
    Mohammadzadeh M; Behnaz F; Golshan Z
    J Infect Public Health; 2013 Apr; 6(2):120-4. PubMed ID: 23537825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
    Asilian A; Sadeghinia A; Faghihi G; Momeni A
    Int J Dermatol; 2004 Apr; 43(4):281-3. PubMed ID: 15090013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.
    Sadeghian G; Nilforoushzadeh MA
    Int J Dermatol; 2006 Jul; 45(7):819-21. PubMed ID: 16863518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasis.
    Córdoba S; Gandolfo Cano M; Aguado M; Huerta-Brogera M; Romero A; Martínez-Morán C; Borbujo J
    Allergy; 2012 Dec; 67(12):1609-11. PubMed ID: 23067046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by
    Eskandari SE; Khamesipour A; Jaafari MR; Javadi A; Mohammadi AM; Valian HK; Nassiri-Kashani M; Goyonlo VM; Firooz A
    Iran J Microbiol; 2021 Oct; 13(5):718-723. PubMed ID: 34900170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis.
    Esfandiarpour I; Farajzadeh S; Rahnama Z; Fathabadi EA; Heshmatkhah A
    Int J Dermatol; 2012 Oct; 51(10):1221-5. PubMed ID: 22994669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic effect of ozonated olive oil plus glucantime on human cutaneous leishmaniasis.
    Aghaei M; Aghaei S; Sokhanvari F; Ansari N; Hosseini SM; Mohaghegh MA; Hejazi SH
    Iran J Basic Med Sci; 2019 Jan; 22(1):25-30. PubMed ID: 30944704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New world cutaneous leishmaniasis treated with intralesional injection of pentavalent antimony.
    Shin JY; Lee YB; Cho BK; Park HJ
    Ann Dermatol; 2013 Feb; 25(1):80-3. PubMed ID: 23467266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis.
    Pourmohammadi B; Motazedian MH; Handjani F; Hatam GH; Habibi S; Sarkari B
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):502-8. PubMed ID: 21706927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.
    Rajabi O; Layegh P; Hashemzadeh S; Khoddami M
    Dermatol Ther; 2016 Sep; 29(5):358-363. PubMed ID: 27073044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.